|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||229.98 - 232.51|
|52 Week Range||203.70 - 288.78|
|PE Ratio (TTM)||122.24|
|Earnings Date||Oct 31, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||1.36 (0.57%)|
|1y Target Est||292.56|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Industrials sector is rising.
Teleflex (TFX) rides high on a strong year-over-year revenue improvement, banking on balanced segmental growth and wide geographical expansion.
Teleflex (TFX) delivered earnings and revenue surprises of 2.49% and -1.19%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Wayne, Pennsylvania-based company said it had a loss of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to $2.47 per share. The results topped Wall Street expectations. The ...
Teleflex Incorporated announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock. The dividend is payable September 14, 2018 to shareholders of record at the close of business on August 15, 2018.
Teleflex (TFX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.
This analysis is intended to introduce important early concepts to people who are starting to invest and looking to gauge the potential return on investment in Teleflex Incorporated (NYSE:TFX). TeleflexRead More...
Teleflex Incorporated will present at the World Congress on Vascular Access 2018 in Copenhagen, Denmark from June 20th to June 22nd. Teleflex’s theme will be Right Line, Right Patient, Right Time™.
NEW YORK, June 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ConocoPhillips, ...
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results of an independent analysis measuring costs and patient outcomes of the UroLift System compared to transurethral resection of the prostate .
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced its sponsorship of the fifth annual “Drive for Men’s Health” event. Funds raised by this campaign will be donated to Florida Polytechnic University and Cochrane Urology, a division of Cochrane Collaboration, to support the latest research, education, and awareness-generating efforts in the mission to improve men’s health. The event, now in its fifth consecutive year, is an initiative launched by Dr. Jamin Brahmbhatt and Dr. Sijo Parekattil, co-directors of The PUR Clinic (Personalized Urology & Robotics) at South Lake Hospital in Clermont, Florida.
Teleflex Incorporated (TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the LMA® Gastro™ Airway and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress in Copenhagen, Denmark on June 2 – 4, 2018. Throughout ESA 2018, Teleflex will focus on the LMA® Gastro™ Laryngeal Mask Airway and the Arrow EZ-IO® Intraosseous Vascular Access System. Featuring an integrated endoscope channel that provides esophageal access while allowing the Anesthetist to establish an Airway during endoscopic procedures the LMA® Gastro™ Airway is our LMA® Airway Portfolio’s new family member.
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated , is scheduled to speak at the 39th Annual Goldman Sachs Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, California, on Wednesday, June 13, 2018 at 2:40 p.m.
Teleflex (TFX) had its Relative Strength (RS) Rating upgraded from 68 to 74 Thursday -- a welcome improvement, but still shy of the 80 or higher score you look for. [ibd-display-video id=2368044 width=50 float=left autostart=true] When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
Abiomed’s (ABMD) net income has grown at a three-year and five-year average of 95.1% and 120.4%, respectively. The company’s pre-tax margin grew from 10.7% in 2013 to 20.5% in 2017. ABMD beat the medical device industry and the S&P 500 between 2013 and 2017. The market cap gained 680% between 2013 and 2017.
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (TFX) focused on addressing unmet needs in the field of urology, today announced that the American Urological Association (AUA) has recommended the use of the UroLift® System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). In its newly released clinical guidelines developed by a panel of experts in the field, the AUA recommends that the UroLift Prostatic Urethral Lift procedure should be considered for the management of men’s lower urinary tract symptoms attributed to BPH.
Teleflex Incorporated , a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will showcase its complex PCI product portfolio and the Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump at the EuroPCR being held in Paris, France on May 22 – 25, 2018.
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced a series of presentations planned for the 113th Annual Meeting of the American Urological Association taking place May 18 - 21 in San Francisco.
Teleflex Incorporated , a leading global provider of medical devices, will provide an update on its business and address its 3-year business growth strategy and financial goals during its 2018 Analyst & Investor Day today in New York City.
Teleflex Incorporated (NYSE:TFX) generated a below-average return on equity of 6.63% in the past 12 months, while its industry returned 11.05%. An investor may attribute an inferior ROE to aRead More...